Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
June 14, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and...
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
June 11, 2024 16:05 ET
|
Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Laboratory Information Management System (LIMS) Market Report, 2024-2030 - Growing Use of LIMS in the Cannabis Industry Presenting Lucrative Business Opportunities
June 11, 2024 11:33 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Global Laboratory Information Management System (LIMS) Market by Type (Industry), Component (Software, Service), Deployment (On-premise, Cloud (SaaS,...
WellSpan Health Partners with Jersey College to Establish a Dedicated School of Nursing in South Central Pennsylvania
June 11, 2024 09:41 ET
|
WellSpan Health
York, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- WellSpan Health and Jersey College, an accredited post-secondary institution specializing in nursing education, have received regulatory approval to...
Astra Energy Inc. Provides Shareholder Update Regarding Regreen Technologies Inc.
June 11, 2024 08:30 ET
|
Astra Energy Inc.
SAN DIEGO, CA, June 11, 2024 (GLOBE NEWSWIRE) -- - Spin-out is in process with a final plan expected by 30 June 2024 - Regreen founder to return 10 million shares to Astra treasury This follows...
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
June 01, 2024 08:00 ET
|
Kymera Therapeutics, Inc.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement...
RAVE Coffee Gets Wholesalers Buzzing with Direct-to-Roaster Marketplace
May 27, 2024 15:27 ET
|
RAVE Coffee
Cirencester, UK, May 27, 2024 (GLOBE NEWSWIRE) -- Rave Coffee, the renowned specialty coffee roaster, has launched a standalone website expressly for wholesale and commercial customers....
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
May 23, 2024 17:00 ET
|
Kymera Therapeutics, Inc.
Abstract released today highlights safety, pharmacodynamic and clinical response data with additional data to be presented in a poster session on June 1, 2024 KT-253 Phase 1 study ongoing with...
A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research
May 22, 2024 10:23 ET
|
Trial Equity
Trial Equity and Miller Tanner Associates are partnering to expand clinical trial participation to address the gap in diversity.
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.